LAG3 and neoplasm: By contrast, a recent report showed that chronic stimulation of adaptive NK cells from HCMV seropositive donors via NKG2C and IL-15, NKp30, or NKG2D increased PD-1 and LAG-3 surface expression, downregulating NK activity during subsequent interactions with tumor targets (136).